Every year, Forbes publishes the list of billionaires around the world, recording the assets of the world's richest people, and the pharmaceutical industry is no exception. In early March of this year, a total of 30 pharmaceutical companies were selected in the new list published by Forbes.
However, the data is constantly updated every day and the rankings will change. This article sorts out the new medical shackles in the ranks of billionaires in 2015 (incomplete statistics, in no particular order, for reference only, if there are omissions or errors, hope the background is correct!).
Zeng Shaogui Hanyu Pharmaceutical
Shares in Shenzhen Hanyu Pharmaceutical Co., Ltd., a peptide drug supplier listed on the Shenzhen Stock Exchange, rose sharply. Under the impetus, Zeng Shaogui, the chairman of the company with 23% of the company’s shares, ranks among the billionaires in the world. The price of RMB 30.1 is calculated, and these shares are worth more than $1 billion.
As of May 1, Hanyu Pharmaceutical's operating income was 123 million yuan, an increase of 81.13% year-on-year, and net profit was 38 million yuan.
Guan Yanbin Sunflower Pharmaceutical
Sunflower Pharmaceuticals was listed on the Shenzhen Stock Exchange in December last year, issuing 36.5 million shares at a price of 36.53 yuan, raising 1.3 billion yuan ($215 million). Since then, the stock has risen by more than 200%. According to the previous closing price of 131.85 yuan, Guan Yanbin holds a value of 1.2 billion US dollars. Therefore, Guan Yanbin, the 60-year-old chairman of the Sunflower Pharmaceutical Group, has also become a billionaire.
As of May 1, the operating income of Sunflower Pharmaceuticals was 704 million yuan, a year-on-year increase of 16.87%, and the net profit was 0.84 billion yuan.
Chen Yunqin Ningbo Daiwei Medical
Chen Yunqin, the 73-year-old vice chairman of Ningbo Dawei Medical Devices Co., Ltd., became a billionaire after the stock price of this baby medical equipment company rose. Chen Yunqin and his sons Chen Zaihong and Chen Zaiwei jointly own 72% of Ningbo Dawei. Excluding pledge shares, the value of the closing price on May 20 is $1.3 billion.
As of May 1, Dawei Medical's operating income was 61 million yuan, a year-on-year increase of 4.31% and a net profit of 0.17 billion yuan.
Zhao Bingxian Shandong Wohua Medicine
Zhao Bingxian, chairman of Shandong Wohua Pharmaceutical Technology Co., Ltd., a Chinese herbal medicine supplier listed on the Shenzhen Stock Exchange, has become a new billionaire due to a 500% surge in share prices. Zhao Bingxian, 51, owns a 40% stake in Shandong Wohua Pharmaceutical, which is valued at $1 billion based on the closing price on May 20. This valuation includes cash dividends received.
In the first quarter of 2015, Wohua Pharmaceuticals revenue was US$13.47 million, up 17% year-on-year; net profit was 19.05 million yuan, or US$3.07 million, up more than 500%.
Wang Yunfu Zhejiang Haixiang Pharmaceutical
Wang Yunfu, 52, is the chairman of Donggang Industry and Trade Group. After the newly-controlled stock price of Zhejiang Haixiang Pharmaceutical, a company listed on the Shenzhen Stock Exchange, he became a billionaire. In October last year, Wang Yunfu injected Taizhou Qianjin Chemical Co., Ltd., which owns 90% of his shares, into Haixiang Pharmaceutical. After that, Wang Yunfu and his son Wang Yangchao obtained a 38% stake in the listed company. After discounting the mortgage shares, according to the previous closing price of 21.96 yuan, the total value of Wang Yunfu's shareholding has now reached 1.1 billion US dollars.
As of May 1, Haixiang Pharmaceutical's operating income was 620 million yuan, a year-on-year increase of 129.50%, and net profit was 161 million yuan.
Hu Jiqiang Zhejiang Kang Enbei
In 2004, under the leadership of Hu Jiqiang, Zhejiang Kangenbei Pharmaceutical Co., Ltd., a subsidiary of Kang Enbei Group, was listed on the Shanghai Stock Exchange. The company achieved revenue of 3.6 billion yuan ($576.7 million) in 2014, with a net profit of 552 million yuan ($89 million), an increase of 22% and 32% respectively over the same period of last year. The company's acquisition of a Guizhou Chinese medicine company and the sale of shares of Zhejiang Zuoli Pharmaceutical Co., Ltd. listed in Shenzhen. Hu Jiqiang, after purchasing 35 million new shares in the company's fixed-income this year, currently holds 31% of the shares of the listed company. Therefore, Hu Jiqiang, the 54-year-old chairman of Zhejiang Kangenbei Pharmaceutical Co., Ltd., is also among the billionaire clubs.
As of May 1, Kang Enbei's operating income was 897 million yuan, a year-on-year increase of 22.41%, and net profit was 1.25%, down -9.60% year-on-year.
Han Xu Rui Kang Medicine
With the rising share price of Shandong Ruikang Pharmaceutical Co., Ltd., a pharmaceutical distribution company listed on the Shenzhen Stock Exchange, Han Xu, the chairman of the company, is now among the billionaires in the world.
According to Forbes Chinese.com, Han Xu, 49, and his wife, Zhang Renhua, jointly own 42% of Ruikang Pharmaceutical. After deducting the mortgage shares, the total value is $1.1 billion based on the stock price on April 12. Zhang Renhua is now the vice chairman and general manager of Ruikang Pharmaceutical. The company's share price rose by 200% last year, and the general rebound in China's stock market has created a dozen of China's new billionaires.
As of May 1, Ruikang Pharmaceutical's operating income was 2.796 billion yuan, a year-on-year increase of 26.11% and a net profit of 0.51 billion yuan.
Shao Qinxiang Garden Bio
Zhejiang Garden Biotech Co., Ltd., a vitamin supplier listed in Shenzhen, rose. The company and its privately held parent company, Garden Group Chairman Shao Qinxiang, rank among the world's billionaires. It is reported that Zhejiang Garden Biotech, a biochemical subsidiary of Garden Group, was listed in Shenzhen in 2014, raising 159 million yuan, or about 25.7 million US dollars. The company claims to be the world's largest producer of vitamin D3.
Shao Qinxiang and his daughter own 42% of the listed company, which is calculated according to the closing price of 48.54 yuan per share on April 7. These shares are worth 1.9 billion yuan, or about 299 million US dollars. In addition, Shao Qinxiang ranked 353th in the 2014 Forbes China Rich List, with a net asset of $750 million.
As of May 1, Garden Biotechnology's operating income was 34 million yuan, a year-on-year increase of 13.30%, and net profit was 0.067 billion yuan.
Huaxuan De Jiuzhou Pharmaceutical
Thanks to the rising share price of this active pharmaceutical ingredient supplier listed in Shenzhen, Hua Xuande, chairman of Zhejiang Jiuzhou Pharmaceutical Co., Ltd., is also among the billionaires in the world. It is reported that the Huaxuande family owns 60% of the listed company. Based on the closing price of 49.93 yuan per share on April 7, these shares are worth 6.4 billion yuan, or about 1 billion dollars. The stock has tripled since its listing.
As of May 1, Kyushu Pharmaceutical's operating income was 337 million yuan, a year-on-year increase of 12.96%, and net profit was 0.405 billion yuan.
Liang Guiqiu Shang Rong Medical
Liang Guiqiu, chairman of Shenzhen Shangrong Medical Co., Ltd., holds 41% of the company's shares, and its total value reached $1 billion on May 19. It is reported that Shangrong Medical's first quarter 2015 revenue was 301.6 million yuan ($48.6 million), up 29% year-on-year; first quarter net profit was 34.7 million yuan ($5.6 million), up year-on-year 31.7%. With the increase in sales, Shangrong Medical expects net profit to rise by 50% in the first half of the year to reach 77.1 million yuan ($12.4 million).
As of May 1, Shangrong Medical's operating income was 301.6 million yuan, a year-on-year increase of 28.91%, and net profit was 35 million yuan.
Zou Bingde Meikang Bio
On May 7, the share price of Ningbo Meikang Biotechnology Co., Ltd. rose to a historical high in the Shenzhen Stock Exchange. The chairman of the in vitro diagnostic company, Zou Bingde, joined the ranks of billionaires around the world.
Zou Bingde, aged 43, holds 61% of the shares of Meikang Bio, based on the closing price of 102.74 yuan on May 7, valued at 1.1 billion US dollars (7.1 billion yuan).
As of May 1, Kangmei Pharmaceutical's operating income was 5.02 billion yuan, a year-on-year increase of 19.20%, and net profit was 818 million yuan.
Chen Haibin Dean diagnosis
With the rising share price of Zhejiang Dean Diagnostics Technology Co., Ltd., a health care service company listed on the Shenzhen Stock Exchange, its chairman Chen Haibin has now become one of the world's billionaires. Chen Haibin owns 38% of Diane's diagnosis, which is calculated based on Thursday's closing price of 90.8 yuan. After deducting the mortgage shares, its value is 6.7 billion yuan (about 1.1 billion US dollars). In the past year, the stock price of this Shenzhen stock company has more than doubled.
As of May 1, Dean's diagnostic revenue was 329 million yuan, a year-on-year increase of 30.12%, and net profit was 0.27 billion yuan.
Zheng Xiaodong Dong Fulong
Zheng Xiaodong, chairman of Shanghai Dongfulong Technology Co., Ltd., a pharmaceutical equipment manufacturer, holds a 63% stake in Dongfulong.
According to Forbes estimates, the current stock value he holds and the most recent dividend income total more than $1 billion. Zheng Xiaodong also ranked 256th in the 2014 Forbes China Rich List with a personal net worth of $940 million.
It is reported that Dongfulong achieved revenue of 1.3 billion yuan in 2014, which is about 200 million US dollars, up 23% year-on-year; net profit increased 26% to 335.9 million yuan, about 53.5 million US dollars.
Chengdu JRT is a world leader in the design and manufacture of highly accurate, precise and digital and analogue laser measurement sensors, including serial laser distance transducer,usb laser distance module,distance module ttl laser sensor rs232/RS485/Bluetooth. These Laser Distance Sensor products are widely used in many smart industrial precise measurement soluitons: robot,crane,etc. This laser distance measure technology, combined with the high speed, 1mm high resolution and accurate measurement, specially the micro laser sensor(41*17*7mm),will confidently and accurately solve your precision measurement problem.
Laser Distance Measurement,Laser Measurement Sensors,Laser Distance Measurement,Smart Measure Sensor
Chengdu JRT Meter Technology Co., Ltd , https://www.irdistancesensor.com